Other Viruses Citation List:
May 28 - June 10, 2010
Hepatitis C Virus
1. PSI-7851, a Pronucleotide of {beta}-D-2'-Deoxy-2'-Fluoro-2'-C-Methyluridine Monophosphate: A Potent and Pan-Genotype Inhibitor of Hepatitis C Virus Replication. Lam, A.M., E. Murakami, C. Espiritu, H.M. Micolochick Steuer, C. Niu, M. Keilman, H. Bao, V. Zennou, N. Bourne, J.G. Julander, J.D. Morrey, D.F. Smee, D.N. Frick, J.A. Heck, P. Wang, D. Nagarathnam, B.S. Ross, M.J. Sofia, M.J. Otto, and P.A. Furman. Antimicrob Agents Chemother. [Epub ahead of print]; PMID[20516278].
[Pubmed]. OV_0528-061010.
2. Phosphoramidate ProTides of 2'-C-Methylguanosine as Highly Potent Inhibitors of Hepatitis C Virus. Study of Their in Vitro and in Vivo Properties. McGuigan, C., A. Gilles, K. Madela, M. Aljarah, S. Holl, S. Jones, J. Vernachio, J. Hutchins, B. Ames, K.D. Bryant, E. Gorovits, B. Ganguly, D. Hunley, A. Hall, A. Kolykhalov, Y. Liu, J. Muhammad, N. Raja, R. Walters, J. Wang, S. Chamberlain, and G. Henson. J Med Chem. [Epub ahead of print]; PMID[20527890].
[Pubmed]. OV_0528-061010.
3. The Efficacy of siRNAs against Hepatitis C Virus Is Strongly Influenced by Structure and Target Site Accessibility. Sagan, S.M., N. Nasheri, C. Luebbert, and J.P. Pezacki. Chem Biol. 17(5): p. 515-527; PMID[20534349].
[Pubmed]. OV_0528-061010.
4. Preclinical characterization of the antiviral activity of SCH 900518 (Narlaprevir), a novel mechanism-based inhibitor of hepatitis C virus NS3 protease. Tong, X., A. Arasappan, F. Bennett, R. Chase, B. Feld, Z. Guo, A. Hart, V. Madison, B. Malcolm, J. Pichardo, A. Prongay, R. Ralston, A. Skelton, E. Xia, R. Zhang, and F.G. Njoroge. Antimicrob Agents Chemother. 54(6): p. 2365-70; PMID[20308381].
[Pubmed]. OV_0528-061010.
5. Multiple effects of silymarin on the hepatitis C virus lifecycle. Wagoner, J., A. Negash, O.J. Kane, L.E. Martinez, Y. Nahmias, N. Bourne, D.M. Owen, J. Grove, C. Brimacombe, J.A. McKeating, E.I. Pecheur, T.N. Graf, N.H. Oberlies, V. Lohmann, F. Cao, J.E. Tavis, and S.J. Polyak. Hepatology. 51(6): p. 1912-21; PMID[20512985].
[Pubmed]. OV_0528-061010.
Hepatitis B Virus
6. Bioactive flavones and biflavones from Selaginella moellendorffii Hieron. Cao, Y., N.H. Tan, J.J. Chen, G.Z. Zeng, Y.B. Ma, Y.P. Wu, H. Yan, J. Yang, L.F. Lu, and Q. Wang. Fitoterapia. 81(4): p. 253-8; PMID[19775597].
[Pubmed]. OV_0528-061010.
Human Cytomegalovirus
7. Novel anticytomegalovirus activity of immunosuppressant mizoribine and its synergism with ganciclovir. Kuramoto, T., T. Daikoku, Y. Yoshida, M. Takemoto, K. Oshima, Y. Eizuru, Y. Kanda, T. Miyawaki, and K. Shiraki. J Pharmacol Exp Ther. 333(3): p. 816-21; PMID[20194528].
[Pubmed]. OV_0528-061010.
HSV-1 Virus
8. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2. Chono, K., K. Katsumata, T. Kontani, M. Kobayashi, K. Sudo, T. Yokota, K. Konno, Y. Shimizu, and H. Suzuki. J Antimicrob Chemother. [Epub ahead of print]; PMID[20534624].
[Pubmed]. OV_0528-061010.
Citations from the ISI Web of Knowledge Listings for O.I.
9. Human Cytomegalovirus Protein pUL117 Targets the Mini-Chromosome Maintenance Complex and Suppresses Cellular DNA Synthesis. Qian, Z.K., V. Leung-Pineda, B.Q. Xuan, H. Piwnica-Worms, and D. Yu. PLOS Pathogens. 6(3); ISI[000277720400024].
[WOS]. OV_0528-061010.